Study guide

12.1 Pathophysiology & Transport Management of Pediatric Septic Shock

Neonatal Pediatric Transport C-NPT

Track your progress as you read

Finished sections get a check mark.

1 Introduction: The C-NPT Exam

About the C-NPT Exam: 2026 Format, Eligibility & Content Outline

2 Chapter 1: Transport Systems, Regulatory Framework & Legal Issues

1.1 Transport System Architecture, Accreditation (CAMTS) & Dispatch Triage 1.2 Regulatory & Legal Mandates: EMTALA, HIPAA, Consent & Documentation 1.3 Medical Direction, Scope of Practice & Ethical Considerations

3 Chapter 2: Safety, Communication, Crew Resource Management & Transport Environment

2.1 Crew Resource Management (CRM), Situational Awareness & Sterile Cockpit 2.2 Aircraft & Ground Ambulance Operations, Landing Zones & Vehicle Dynamics 2.3 Environmental Hazards, Weather Minimums & In-Flight Emergency Procedures 2.4 Communication in Transport: Peer Handoffs, Age-Appropriate Care, Families & Crew Stressors 2.5 Infection Control, PPE, Scene Safety & Disaster/Evacuation Planning

4 Chapter 3: Flight Physiology & Environmental Stressors

3.1 Physical Gas Laws & Transport Implications (Boyle, Dalton, Charles, Henry, Graham) 3.2 Altitude Hypoxia, Barometric Pressure Changes & Dysbarism 3.3 Acceleration Forces (G-forces), Vibration & Acoustic Stress in Transit 3.4 Thermoregulation Physics & Neutral Thermal Environment in Transit

5 Chapter 4: Invasive Procedures & Transport Monitoring

4.1 Advanced Airway Management & Endotracheal Intubation in Transit 4.2 Pleural Decompression (Needle Thoracostomy & Chest Tube Management) 4.3 Vascular Access: Umbilical Lines (UAC/UVC), Intraosseous (IO) & Arterial Lines

6 Chapter 5: Transport Equipment, Respiratory Physiology & Mechanical Ventilation

5.1 Transport Incubators (Isolettes), Thermal Control & Electrical/Gas Power Systems 5.2 Portable Ventilators & Modes (PC, VC, PRVC, High Frequency) 5.3 Gas Cylinder Duration Calculations, Oxygen Delivery & Inhaled Nitric Oxide (iNO) 5.4 Respiratory Physiology: Acid-Base Balance, Oxygenation, Lung Mechanics & Troubleshooting

7 Chapter 6: Transport Pharmacology, Resuscitation, Fluids & Electrolytes

6.1 Vasoactive Infusions & Inotropes (Epinephrine, Dopamine, Dobutamine, Milrinone) 6.2 Sedation, Analgesia & Neuromuscular Blockade in Transport 6.3 Prostaglandin E1 (Alprostadil) & Surfactant Replacement Therapy 6.4 Resuscitation Protocols (NRP, PALS) & Shock Fluid Resuscitation 6.5 Antimicrobial Pharmacology in Neonatal & Pediatric Transport 6.6 Post-Resuscitation Care, Defibrillation & Cardioversion in Transit, ECMO Indications & the Transport-vs-Stay Decision 6.7 Fluid & Electrolyte Therapy Across the Ages: Maintenance, Dehydration, Fluid Overload & Electrolyte Emergencies

8 Chapter 7: Neonatal Respiratory Pathologies & Management

7.1 Respiratory Distress Syndrome (RDS) & Surfactant Deficiency 7.2 Meconium Aspiration Syndrome (MAS) & Persistent Pulmonary Hypertension (PPHN) 7.3 Transient Tachypnea (TTN), Neonatal Pneumothorax & Congenital Diaphragmatic Hernia (CDH) 7.4 Neonatal Upper Airway Anomalies, Aspiration, Pneumonia, Chronic Lung Disease & Respiratory Failure

9 Chapter 8: Neonatal Cardiovascular Critical Care

8.1 Ductal-Dependent Cyanotic Congenital Heart Defects (TGA, TOF, Tricuspid Atresia) 8.2 Ductal-Dependent Systemic Blood Flow Lesions (HLHS, Coarctation, Interrupted Arch) 8.3 Neonatal Arrhythmias, Cardiogenic Shock & Post-Resuscitation Care 8.4 Acyanotic Congenital Heart Lesions, Patent Ductus Arteriosus, Obstructed TAPVR & Neonatal Heart Failure

10 Chapter 9: Neonatal Neurological & Metabolic Crises

9.1 Hypoxic-Ischemic Encephalopathy (HIE) & Passive/Active Therapeutic Hypothermia 9.2 Neonatal Seizures & Intraventricular Hemorrhage (IVH) 9.3 Neonatal Hypoglycemia, Electrolyte Derangements & Hyperbilirubinemia 9.4 Subgaleal Hemorrhage, Neonatal Sepsis & Meningitis, and Perinatal Substance Exposure (NOWS)

11 Chapter 10: Neonatal Surgical Emergencies, Neural Tube Defects & ELBW Care

10.1 Abdominal Wall Defects (Gastroschisis vs. Omphalocele) & TEF/Esophageal Atresia 10.2 Necrotizing Enterocolitis (NEC), Malrotation with Volvulus & Intestinal Obstruction 10.3 Care of the Extremely Low Birth Weight (ELBW) Infant (<1000g) in Transit 10.4 Neural Tube Defects: Myelomeningocele, Encephalocele & Transport of the Newborn With an Open Spinal Defect

12 Chapter 11: Pediatric Respiratory Emergencies

11.1 Acute Upper Airway Obstruction (Croup, Epiglottitis, Bacterial Tracheitis, Foreign Body) 11.2 Lower Airway Crises: Status Asthmaticus & Severe Bronchiolitis 11.3 Pediatric Acute Respiratory Distress Syndrome (PARDS) & Severe Pneumonia

13 Chapter 12: Pediatric Shock & Cardiovascular Crises

12.1 Pathophysiology & Transport Management of Pediatric Septic Shock 12.2 Hypovolemic, Cardiogenic & Anaphylactic Shock in Children 12.3 Pediatric Cardiac Emergencies: SVT, Ventricular Arrhythmias & Myocarditis 12.4 Pediatric Cardiovascular Crises: Palliated Congenital Heart Disease, Pulmonary Hypertensive Crisis, Pericarditis & Tamponade, Hypertensive Emergency & Anterior Mediastinal Mass

14 Chapter 13: Pediatric Neurological Emergencies & Trauma

13.1 Status Epilepticus, Altered Mental Status & Meningitis/Encephalitis 13.2 Pediatric Traumatic Brain Injury (TBI) & Increased Intracranial Pressure (ICP) 13.3 Blunt/Penetrating Trauma, Spinal Motion Restriction & Thermal Burns 13.4 Non-Accidental Trauma, Smoke Inhalation (Carbon Monoxide & Cyanide) & Heat Illness

15 Chapter 14: Pediatric Toxicological, Environmental & Endocrine Emergencies

14.1 Common Pediatric Toxic Ingestions, Poisonings & Antidotes 14.2 Diabetic Ketoacidosis (DKA) & Environmental Emergencies (Submersion, Hypothermia) 14.3 Button Battery & Foreign-Body Ingestions, Bites & Envenomations, and Hazardous-Material Exposures

16 Chapter 15: Pediatric Metabolic & Hematologic Emergencies

15.1 Anemia, Sickle Cell Disease, Coagulopathies & Blood Product Administration 15.2 Oncologic Emergencies, Acute Kidney Injury & Pediatric Electrolyte Crises

12.1 Pathophysiology & Transport Management of Pediatric Septic Shock

Key Takeaways Explain This Topic AI

Pediatric patients maintain blood pressure through profound compensatory vasoconstriction and tachycardia until late in the shock continuum; hypotension is an ominous, pre-terminal finding defining decompensated shock (minimum acceptable systolic blood pressure formula: 70 + [2 × age in years] for ages 1–10; <60 mmHg for neonates, <70 mmHg for infants).

Pediatric septic shock predominantly presents as 'cold shock' (~60% of community-acquired cases), characterized by low cardiac output, elevated systemic vascular resistance (SVR), delayed capillary refill (>2 seconds), and cool, mottled extremities, in contrast to adult distributive 'warm shock' (bounding pulses, flash capillary refill <1 second, wide pulse pressure).

The Surviving Sepsis Campaign and PALS golden hour resuscitation bundle mandates rapid vascular access (IV or IO within 5 minutes), 10–20 mL/kg balanced crystalloid boluses over 5–20 minutes with continuous reassessment for hepatomegaly and pulmonary rales, and broad-spectrum antibiotics within 60 minutes.

Fluid-refractory cold shock is commonly treated with early inotropic support using Epinephrine (0.05–0.3 mcg/kg/min) to overcome myocardial depression and improve systemic perfusion; fluid-refractory warm shock is commonly treated with Norepinephrine (0.05–0.3 mcg/kg/min) to restore systemic vascular tone.

Stress-dose hydrocortisone is reserved for catecholamine-refractory septic shock or known adrenal insufficiency; the Surviving Sepsis Campaign suggests against it when fluids and vasopressors restore stability.

Last updated: September 2026

Pathophysiology & Transport Management of Pediatric Septic Shock

Septic shock in the pediatric population is a life-threatening medical emergency characterized by severe dysregulation of the host systemic inflammatory response to an invasive infection, culminating in profound cellular hypoxia, tissue hypoperfusion, and multiorgan dysfunction syndrome (MODS). When dispatched to transport a critically ill infant or child with suspected sepsis, transport specialists must possess a sophisticated understanding of pediatric cardiovascular physiology. Interventions executed during the initial "golden hour" of resuscitation directly determine neurocognitive outcomes and survival.

The Cellular & Systemic Pathophysiology of Pediatric Sepsis

The septic cascade begins when pathogen-associated molecular patterns (PAMPs)—such as bacterial lipopolysaccharide (endotoxin) from gram-negative bacilli or peptidoglycans and lipoteichoic acid from gram-positive cocci—bind to pattern recognition receptors (such as Toll-like receptors) on host immune effector cells. This molecular interaction triggers widespread release of pro-inflammatory cytokines, including Tumor Necrosis Factor-alpha (TNF- α \alpha α ), Interleukin-1 (IL-1), Interleukin-6 (IL-6), and Platelet-Activating Factor (PAF). Invasive Pathogen (PAMPs: Endotoxins / Peptidoglycans)

  • │
  • ▼
  • Toll-Like Receptor Activation on Monocytes & Macrophages
  • │
  • ▼
  • Massive Pro-Inflammatory Cytokine Cascade (TNF-α, IL-1, IL-6)
  • │
  • ┌────┴──────────────────────────────┬──────────────────────────────┐
  • ▼ ▼ ▼
  • Endothelial Glycocalyx Disruption Microvascular Thrombosis & DIC Myocardial Depression
  • │ │ │
  • Capillary Leak Syndrome Tissue Hypoperfusion Decreased Stroke Volume
  • Intravascular Hypovolemia Lactic Acidosis Decreased Ejection Fraction

This cytokine storm produces three primary pathophysiological derangements:

Endothelial Glycocalyx Disruption & Capillary Leak: Inflammatory mediators degrade the vascular endothelial glycocalyx and loosen inter-endothelial tight junctions. Plasma proteins, albumin, and intravascular fluids extravasate into the interstitial tissue spaces. This profound capillary leak produces rapid, progressive intravascular hypovolemia, tissue edema, and impaired oxygen diffusion.

Microvascular Thrombosis & Disseminated Intravascular Coagulation (DIC): Concurrently, inflammatory cytokines stimulate tissue factor expression, triggering the extrinsic coagulation cascade while downregulating endogenous anticoagulants (protein C, protein S, and antithrombin III). Fibrin deposition and microvascular thrombi occlude capillaries, creating severe ventilation-perfusion mismatch, tissue ischemia, cytopathic hypoxia, and anaerobic lactic acidosis. Consumptive coagulopathy manifests clinically as petechiae, ecchymoses, and purpura fulminans.

Pediatric Myocardial Depression: Circulating myocardial depressant substances downregulate myocardial beta-adrenergic receptors and interfere with sarcoplasmic reticulum calcium handling. Despite intact compensatory adrenergic signaling, intrinsic myocardial contractility and ventricular compliance become markedly impaired, limiting stroke volume.

Compensated vs Decompensated (Hypotensive) Shock

Recognizing the stage of circulatory failure is paramount in pediatric critical care. Children possess remarkable physiological reserve, governed by unique developmental cardiovascular dynamics:

Fixed Stroke Volume Dependency: The immature pediatric myocardium contains a higher ratio of non-contractile connective tissue to contractile myofibrils and has an underdeveloped sarcoplasmic reticulum. Consequently, the pediatric heart cannot dramatically increase stroke volume via the Frank-Starling mechanism. Cardiac output is almost exclusively rate-dependent ( C O = H R × S V CO = HR \times SV CO = H R × S V ).

Sympathoadrenal Vasoconstriction: To defend vital organ perfusion (brain and heart) during hypovolemia, children mount an intense autonomic sympathoadrenal response, releasing endogenous epinephrine and norepinephrine that induce severe peripheral vasoconstriction.

Compensated Shock

In compensated shock , intense peripheral vasoconstriction and marked tachycardia maintain a normal systolic arterial blood pressure. The child may lose up to 30% to 40% of effective circulating intravascular volume while maintaining a normotensive reading on the blood pressure monitor. Diagnostic indicators of compensated shock reflect peripheral hypoperfusion and metabolic compensation:

  • Unexplained, persistent tachycardia (often out of proportion to fever or anxiety)
  • Tachypnea (compensating for underlying metabolic lactic acidosis)
  • Prolonged capillary refill time (>2 seconds) or mottled extremities
  • Weak, thready peripheral pulses with preserved central pulses
  • Narrowed pulse pressure (elevated diastolic blood pressure from peripheral vasoconstriction)
  • Decreased urine output (<1 mL/kg/hr in infants and children)
  • Subtle neurological changes: irritability, poor eye contact, or lethargy
  • Decompensated (Hypotensive) Shock

Decompensated shock occurs when physiological compensatory mechanisms become exhausted. Microvascular autoregulation fails, myocardial contractility plummets, and arterial blood pressure collapses. In pediatric patients, hypotension is an exceptionally late and pre-terminal indicator of impending cardiopulmonary arrest.

Clinical Formula: Minimum Acceptable Systolic Blood Pressure (5th Percentile)

Transport specialists must memorize the standardized formulas defining the lower threshold of acceptable systolic blood pressure by age:

  • Term Neonates (0–28 days): Systolic BP < 60 mmHg < 60\text{ mmHg} < 60 mmHg
  • Infants (1–12 months): Systolic BP < 70 mmHg < 70\text{ mmHg} < 70 mmHg

Children (1–10 years): Systolic BP < 70 + ( 2 × age in years ) mmHg \text{Systolic BP} < 70 + (2 \times \text{age in years})\text{ mmHg} Systolic BP < 70 + ( 2 × age in years ) mmHg

Children (>10 years): Systolic BP < 90 mmHg < 90\text{ mmHg} < 90 mmHg

Any blood pressure reading below these thresholds confirms decompensated hypotensive shock and demands immediate aggressive resuscitation.

Hemodynamic Phenotypes: Cold Shock vs Warm Shock

Unlike adult septic shock, which predominantly manifests as distributive "warm shock" with high cardiac output and low systemic vascular resistance (SVR), pediatric community-acquired septic shock presents in approximately 60% of cases as "cold shock" .

Cold Shock (Low Cardiac Output, High SVR)

Physiological Profile: Low cardiac index ( < 3.3 L/min/m 2 <3.3\text{ L/min/m}^2 < 3.3 L/min/m 2 ) paired with elevated systemic vascular resistance.

Clinical Features: Cool, pale, or mottled extremities; weak, thread-like peripheral pulses; delayed capillary refill time (>2 seconds); narrowed pulse pressure (e.g., blood pressure 82/64 mmHg); and progressive oliguria.

Hemodynamic Defect: Profound myocardial depression combined with intense compensatory peripheral vasoconstriction. The left ventricle is pumping against elevated afterload with inadequate intrinsic contractility.

Warm Shock (High Cardiac Output, Low SVR)

Physiological Profile: Elevated cardiac index ( > 5.5 L/min/m 2 >5.5\text{ L/min/m}^2 > 5.5 L/min/m 2 ) paired with low systemic vascular resistance.

Clinical Features: Warm, flushed extremities; bounding "water-hammer" peripheral pulses; brisk or flash capillary refill (<1 second); and widened pulse pressure with low diastolic blood pressure (e.g., blood pressure 86/38 mmHg).

Hemodynamic Defect: Severe systemic vasodilation and loss of arterial vasomotor tone, frequently seen in nosocomial infections or central line-associated bacteremia.

Phenotype Comparison Table

Hemodynamic Variable Cold Shock (Pediatric Prevalent ~60%) Warm Shock (Adult Prevalent / Distributive)

Primary Mechanism Myocardial depression & intense vasoconstriction Pathological vasodilation & loss of arterial tone

Cardiac Output / Index Markedly Decreased ( < 3.3 L/min/m 2 <3.3\text{ L/min/m}^2 < 3.3 L/min/m 2 ) Normal to Elevated ( > 5.5 L/min/m 2 >5.5\text{ L/min/m}^2 > 5.5 L/min/m 2 )

  • Systemic Vascular Resistance Markedly Increased (Vasoconstriction) Markedly Decreased (Vasodilation)
  • Extremity Temperature Cool, pale, mottled, cyanotic Warm, erythrodermic, flushed
  • Capillary Refill Time Prolonged (>2 seconds; often >4 seconds) "Flash" refill (<1 second)
  • Peripheral Pulses Diminished, thread-like, or absent Bounding, wide amplitude
  • Pulse Pressure Narrowed (elevated diastolic pressure) Widened (profoundly depressed diastolic pressure)
  • First-Line Vasoactive Agent Epinephrine (0.05–0.3 mcg/kg/min) Norepinephrine (0.05–0.3 mcg/kg/min)
  • Surviving Sepsis Campaign & PALS Golden Hour Resuscitation Protocol

Transport crews must execute the international Surviving Sepsis Campaign and PALS "Golden Hour" bundle sequentially, titrating therapies against physiological endpoints.

Minute 0 to 5: Recognition & Rapid Vascular Access

Administer high-flow supplemental oxygen via non-rebreather mask or high-flow nasal cannula to support tissue oxygen delivery ( D O 2 = C O × C a O 2 DO_2 = CO \times CaO_2 D O 2 ​ = CO × C a O 2 ​ ). Attach continuous ECG, pulse oximetry, and non-invasive blood pressure monitoring.

Vascular Access Rule: Attempt peripheral intravenous (PIV) cannulation. If reliable IV access is not achieved within 2 attempts or 90 seconds (and strictly within 5 minutes of encounter), immediately place an Intraosseous (IO) needle (proximal tibia or distal femur). Never delay shock resuscitation attempting repeated peripheral venipunctures.

Minute 5 to 15: Fluid Resuscitation & Serial Reassessment

Fluid Administration: Administer 10 to 20 mL/kg of balanced crystalloid (Plasma-Lyte or Lactated Ringer's are preferred over 0.9% Normal Saline to avoid hyperchloremic metabolic acidosis and renal vasoconstriction) over 5 to 20 minutes.

Push-Pull Technique: Use a 30-mL or 60-mL syringe with a three-way stopcock or a pressure-infuser bag to deliver fluids rapidly. Gravity flow through small-bore pediatric catheters is unacceptably slow.

Mandatory Reassessment Gates: Before and immediately following every fluid bolus, the transport clinician must physically examine:

Liver edge: Palpate the right upper quadrant. An enlarging liver edge descending > 2 cm >2\text{ cm} > 2 cm below the right costal margin indicates right ventricular volume overload.

Pulmonary auscultation: Auscultate bilateral lung bases. New-onset crackles or rales indicate left ventricular volume overload and pulmonary capillary hypertension.

Work of breathing: Worsening tachypnea, grunting, or retractions indicates pulmonary edema.

If hepatomegaly, pulmonary crackles, or worsening respiratory distress emerge, immediately halt fluid boluses . Do not administer further volume.

Minute 15 to 60: Antimicrobial Therapy & Vasoactive Titration

Antimicrobial Timing: Obtain blood cultures rapidly without delaying antibiotic administration beyond 60 minutes. Administer empiric broad-spectrum intravenous/intraosseous antibiotics (e.g., ceftriaxone plus vancomycin 15 mg/kg; cefotaxime is no longer marketed in the U.S.; see Section 6.5).

Fluid-Refractory Shock: Defined as persistent signs of hypoperfusion (abnormal capillary refill, weak pulses, altered mental status, or hypotension) despite 40 to 60 mL/kg of crystalloid, or earlier if fluid overload develops. Do not wait to infuse 60 mL/kg if myocardial dysfunction is clinically obvious.

Choosing a Vasoactive Agent: The 2020 Surviving Sepsis Campaign pediatric guidelines suggest epinephrine or norepinephrine rather than dopamine and found too little evidence to prefer one of the two. Most clinicians choose by physiology:

Cold Shock: Initiate continuous Epinephrine infusion at 0.05 to 0.3 mcg/kg/min . Epinephrine provides potent β 1 \beta_1 β 1 ​ -adrenergic inotropic support (augmenting stroke volume), β 2 \beta_2 β 2 ​ -mediated lusitropy (enhancing diastolic relaxation), and balanced α 1 \alpha_1 α 1 ​ tone to restore mean arterial pressure.

Warm Shock: Initiate continuous Norepinephrine infusion at 0.05 to 0.3 mcg/kg/min . Norepinephrine provides potent α 1 \alpha_1 α 1 ​ -adrenergic vasoconstriction to restore systemic vascular resistance and diastolic blood pressure, improving coronary perfusion.

Peripheral Vasoactive Delivery: If central venous access is absent, begin vasoactive infusions through a dedicated, securely taped peripheral IV or IO line immediately. Do not delay life-saving inotropes waiting for central line placement.

Stress-Dose Hydrocortisone: The Surviving Sepsis Campaign suggests against routine hydrocortisone when fluids and vasopressors restore stability, but it may be used when shock remains refractory to escalating vasoactive support. Children with known adrenal insufficiency or chronic steroid exposure need stress dosing early. A commonly used dose is hydrocortisone about 2 mg/kg IV (maximum 100 mg) , or 50–100 mg/m² per protocol.

Realistic Transport Scenario: Pediatric Septic Shock in Transit

A transport team is dispatched to a rural emergency department to transfer a 3-year-old female (weight 14 kg) with progressive lethargy and high fever. On arrival, the child is obtunded with mottled, pale extremities. Vital signs reveal heart rate 190 bpm, respiratory rate 48 breaths/min, blood pressure 72/52 mmHg (mean arterial pressure 58 mmHg), and capillary refill 4.5 seconds. Dorsalis pedis pulses are impalpable.

The minimum acceptable systolic blood pressure for a 3-year-old child is 70 + ( 2 × 3 ) = 76 mmHg 70 + (2 \times 3) = 76\text{ mmHg} 70 + ( 2 × 3 ) = 76 mmHg . A systolic pressure of 72 mmHg confirms decompensated hypotensive cold shock . Because the outlying team has struggled for 15 minutes to secure a second IV, the transport nurse immediately places a proximal tibial IO needle. The team delivers a rapid bolus of 280 mL (20 mL/kg) of Plasma-Lyte over 10 minutes via push-pull stopcock. Post-bolus exam shows heart rate 182 bpm, blood pressure 74/54 mmHg, and cap refill 4 seconds, with the liver edge remaining unpalpable. A second 280 mL bolus is initiated, but after 140 mL (total 30 mL/kg given), auscultation reveals fine crackles in the right lung base, and the liver edge descends to 2.5 cm below the costal margin.

Recognizing iatrogenic fluid overload and fluid-refractory cold shock, the team instantly halts crystalloid administration. An Epinephrine infusion is initiated via the IO line at 0.1 mcg/kg/min and titrated to 0.15 mcg/kg/min. Ceftriaxone (100 mg/kg) and Vancomycin (15 mg/kg) are administered. Within 20 minutes, the child's heart rate drops to 142 bpm, blood pressure rises to 88/56 mmHg (MAP 66 mmHg), peripheral pulses become palpable, and capillary refill shortens to 2 seconds. The child is safely stabilized and transported by air to the pediatric intensive care unit without endotracheal intubation.

Clinical Pearls for Pediatric Septic Shock

Important

The Blood Pressure Trap: Normal blood pressure does NOT rule out septic shock in children. Intense peripheral vasoconstriction can preserve systolic pressure until 35% to 40% of blood volume is compromised. Always evaluate capillary refill, pulse quality, extremity warmth, and mental status.

Tip

Balanced Crystalloids Prevent Acidosis: Large infusions of 0.9% Normal Saline cause hyperchloremic metabolic acidosis, which exacerbates myocardial depression and triggers renal vasoconstriction. Use balanced crystalloids (Plasma-Lyte or Lactated Ringer's) for volume resuscitation whenever available.

Note

Early Inotrope Initiation: In pediatric septic shock, do not delay vasoactive infusions if perfusion fails to normalize after 40 mL/kg of fluid, or immediately if pulmonary rales or hepatomegaly appear. Early peripheral epinephrine saves lives in pediatric cold shock.

Loading diagram... Pediatric Septic Shock Golden Hour Resuscitation Pathway